Alzheimer's Disease News and Research

RSS

Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.

Simple scan can reveal if people are at increased risk of late-life dementia

Late-life dementia is becoming increasingly common in people after 80 years of age.

27 Jun 2022

The association between handgrip strength and dementia risk in a UK population of middle-aged adults

Researchers analyzed the correlations between HGS, dementia, and neurocognitive outcomes among males and females from the United Kingdom.

27 Jun 2022

LUCID: music, medicine, and machine learning

In this interview, News-Medical speaks to Zoë Thomson, Co-founder and Chief Innovation Officer of LUCID, about how music and machine learning are changing how we approach mental and neuropsychiatric health.

27 Jun 2022

Mice study unravels the role of T. denticola in Alzheimer's disease pathogenesis

Tau hyperphosphorylation is the key characteristic pathological hallmarks of Alzheimer's disease (AD). Recently studies showed periodontitis and periodontal pathogen are significant risk factors for AD.

26 Jun 2022

Study underscores the strong protective effect of flu vaccine against Alzheimer's disease

People who received at least one influenza vaccine were 40% less likely than their non-vaccinated peers to develop Alzheimer's disease over the course of four years, according to a new study from UTHealth Houston.

24 Jun 2022

Nearly all known biological pathways in the brain are linked to Alzheimer's disease

Nearly six million older adults have Alzheimer's disease in the United States, a number expected to double by 2050.

24 Jun 2022

Researchers improve the ability of a protein to repair oxidative DNA damage

Researchers at Karolinska Institutet and SciLifeLab in Sweden describe in a study published in Science how they have improved the ability of a protein to repair oxidative DNA damage and created a new protein function.

23 Jun 2022

Researchers discover two important novel aspects of APOE4 gene in Alzheimer's patients

Alzheimer's disease (AD) is a progressive neurodegenerative disorder and the most common cause of dementia, affecting more than 5.8 million individuals in the U.S.

23 Jun 2022

Acupuncture may help people suffering from chronic tension-type headaches

Acupuncture may reduce headaches for people who have chronic tension-type headaches, according to a study published in the June 22, 2022, online issue of Neurology, the medical journal of the American Academy of Neurology.

22 Jun 2022

A class of protein-cleaving enzymes suspected to play a role in hereditary brain disease

Similar to Alzheimer's disease, the hereditary disease spinocerebellar ataxia type 17 (SCA17) leads to the destruction of brain nerve cells and the premature death of patients.

21 Jun 2022

Increased docosahexaenoic acid intake may lower risk for Alzheimer’s and dementia

An increase in the concentration of DHA in RBCs is associated with a reduced risk of Alzheimer's disease and all-cause dementia

21 Jun 2022

Proteins in liquor could provide information about inflammatory processes in the brain

Alzheimer's, Parkinson's and other neurodegenerative diseases are associated with inflammatory processes in the brain.

20 Jun 2022

MRI-based machine learning approach can accurately predict Alzheimer’s disease

The research uses machine learning technology to look at structural features within the brain, including in regions not previously associated with Alzheimer's.

20 Jun 2022

Fragmented sleep, wakefulness after bedtime linked with lower cognitive function among African Americans

More fragmented sleep and longer periods of wakefulness after bedtime among a group of low-income African American adults were associated with lower cognitive function such as poor attention, according to a new study.

16 Jun 2022

Cost of brand-name antiseizure medications increased by 277% from 2010 to 2018, study finds

The cost of brand-name drugs for epilepsy increased by 277% from 2010 to 2018, according to a study published in the June 15, 2022, online issue of Neurology, the medical journal of the American Academy of Neurology.

16 Jun 2022

LifeArc and UK DRI launch new partnership to accelerate development of new treatments for dementia

LifeArc and the UK Dementia Research Institute (UK DRI) have today launched a new partnership to accelerate development of new diagnostic tests, treatments, and devices from scientific research discoveries to benefit people with dementia, which around 900,000 people in the UK are living with.

15 Jun 2022

Lifestyle factors play a beneficial role in the prevention of Alzheimer's and related dementias

As rates of Alzheimer's disease and other forms of dementia continue to rise in the U.S., new evidence suggests that lifestyle factors such as diet, exercise and sleep play an important role in reducing the risk of developing dementia.

14 Jun 2022

New near-infrared probe may aid in early diagnosis of Alzheimer's disease

Inside the body, some seemingly harmless proteins have sinister potential. In the case of Alzheimer's disease, the amyloid-beta (Aβ) protein, which is vital for brain growth, can become tainted and destroy cells, which leads to forgetfulness and memory loss.

14 Jun 2022

New research provides credible estimates for prevalence of Alzheimer’s-like brain disorder

New National Institutes of Health-funded research shows that the prevalence of brain changes from Limbic-predominant Age-related TDP-43 Encephalopathy (LATE) may be roughly 40% in older adults and as high as 50% in people with Alzheimer's disease.

13 Jun 2022

Study provides the most definitive assessment of new non-Alzheimer’s dementia

Researchers from the University of Kentucky's Sanders-Brown Center on Aging say a paper recently published in Acta Neuropathologica is the most definitive assessment yet of the prevalence of a form of dementia classified in 2019 and now known as LATE.

13 Jun 2022

Alzheimer's Disease News and Research

Further Reading

Simple scan can reveal if people are at increased risk of late-life dementia

The association between handgrip strength and dementia risk in a UK population of middle-aged adults

LUCID: music, medicine, and machine learning

Mice study unravels the role of T. denticola in Alzheimer's disease pathogenesis

Study underscores the strong protective effect of flu vaccine against Alzheimer's disease

Nearly all known biological pathways in the brain are linked to Alzheimer's disease

Researchers improve the ability of a protein to repair oxidative DNA damage

Researchers discover two important novel aspects of APOE4 gene in Alzheimer's patients

Acupuncture may help people suffering from chronic tension-type headaches

A class of protein-cleaving enzymes suspected to play a role in hereditary brain disease

Increased docosahexaenoic acid intake may lower risk for Alzheimer’s and dementia

Proteins in liquor could provide information about inflammatory processes in the brain

MRI-based machine learning approach can accurately predict Alzheimer’s disease

Fragmented sleep, wakefulness after bedtime linked with lower cognitive function among African Americans

Cost of brand-name antiseizure medications increased by 277% from 2010 to 2018, study finds

LifeArc and UK DRI launch new partnership to accelerate development of new treatments for dementia

Lifestyle factors play a beneficial role in the prevention of Alzheimer's and related dementias

New near-infrared probe may aid in early diagnosis of Alzheimer's disease

New research provides credible estimates for prevalence of Alzheimer’s-like brain disorder

Study provides the most definitive assessment of new non-Alzheimer’s dementia

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News